August 2026

Ferric Carboxymaltose: The Iron Infusion Sold as Injectafer

By Your Health Magazine Health Information Team

You have been taking iron tablets, but fatigue, shortness of breath, headaches, or difficulty concentrating still interfere with daily life. Perhaps the tablets upset your stomach, or laboratory tests show that your iron levels remain low. In situations like these, a healthcare professional may recommend intravenous iron—and the name Injectafer may appear in the conversation.

So, what is Injectafer, and how is it related to ferric carboxymaltose? Ferric carboxymaltose is the medication’s generic name, while Injectafer is the ferric carboxymaltose brand name in the United States. It is a prescription iron replacement treatment administered into a vein by a healthcare professional.

What Does Ferric Carboxymaltose Treat?

Ferric carboxymaltose supplies iron directly to the bloodstream. The body needs iron to make hemoglobin, the protein in red blood cells that carries oxygen. When iron stores become too low, a person may develop iron-deficiency anemia and experience symptoms that affect work, exercise, sleep, and concentration.

Injectafer is approved to treat iron-deficiency anemia in adults and children age 1 and older who cannot tolerate oral iron or have not responded adequately to it. It is also used in adults with chronic kidney disease who are not dependent on dialysis. In addition, it may be prescribed for iron deficiency in certain adults with heart failure to improve exercise capacity.

Ferric carboxymaltose is not appropriate for every type of anemia. Low red blood cell counts can result from bleeding, nutritional deficiencies, chronic disease, inherited conditions, or other medical problems. Readers can learn more about anemia, its symptoms, and possible causes. Identifying why iron deficiency developed remains important because an infusion replaces iron but does not correct an underlying source of blood loss or poor absorption.

Why Choose an Infusion Instead of Iron Tablets?

Oral iron is commonly tried first, but it may cause nausea, constipation, abdominal discomfort, or other digestive problems. Some people cannot absorb enough iron through the gastrointestinal tract, while others need iron replacement that cannot be achieved adequately with oral therapy.

An intravenous product bypasses the digestive system and delivers iron into the circulation. Ferric carboxymaltose can provide a substantial amount of iron during a limited number of appointments, although the appropriate treatment schedule depends on body weight, laboratory results, medical history, and the reason for treatment. Patients should not compare or adjust iron doses on their own because IV iron products are not interchangeable dose for dose.

What Happens Before and During an Injectafer Infusion?

Before recommending treatment, a clinician will usually review symptoms, health history, current medications, previous reactions to iron products, and relevant blood tests. Testing may include a complete blood count, ferritin, transferrin saturation, and other studies needed to confirm iron deficiency and investigate its cause.

Injectafer is administered through an IV line in a medical office, infusion center, or hospital outpatient setting. A nurse or other qualified professional monitors the IV site and checks for reactions. Blood pressure may be measured during and after treatment because ferric carboxymaltose can cause a temporary rise in blood pressure.

Patients are observed for at least 30 minutes after each administration and until clinically stable. The number and timing of appointments vary, so the prescribing clinician will create an individual treatment plan. For practical preparation, including questions about coverage and facility charges, see this overview of what to expect when considering iron infusion costs.

How Soon Will You Feel Better?

An iron infusion does not always produce an immediate burst of energy. The body must use the available iron to support red blood cell production and restore depleted stores. Improvement may be gradual, and the response differs according to the severity and cause of the deficiency, other health conditions, and whether ongoing blood loss is present.

Follow-up bloodwork helps determine whether hemoglobin and iron stores are improving. Persistent symptoms do not automatically mean that the infusion failed; fatigue and shortness of breath can have many causes. A healthcare professional should interpret symptoms together with laboratory results rather than relying on how someone feels alone.

Possible Side Effects and Important Risks

Commonly reported reactions in adults include nausea, flushing, dizziness, injection-site reactions, increased blood pressure, skin redness, and low blood phosphate. Headache, vomiting, changes in taste, bruising, or discomfort around the IV site may also occur.

Tell the infusion staff immediately if the IV site becomes painful, swollen, or irritated. If ferric carboxymaltose leaks outside the vein, it can cause brown discoloration of the skin that may be long-lasting.

Low Blood Phosphate

Ferric carboxymaltose can cause hypophosphatemia, meaning the phosphate level in the blood becomes too low. Although some cases have no obvious symptoms, serious or prolonged cases may cause unusual fatigue, muscle weakness or pain, bone or joint pain, softening of the bones, or fractures.

Risk may be greater in people receiving repeated treatment and those with preexisting low phosphate, vitamin D deficiency, malnutrition, inflammatory bowel disease, certain absorption disorders, hyperparathyroidism, or medications that affect kidney handling of phosphate. A clinician may check phosphate levels before repeat courses, particularly when treatment is repeated within a few months or risk factors are present.

Allergic and Infusion Reactions

Serious hypersensitivity reactions, including life-threatening reactions, are uncommon but possible. Treatment must therefore be given where trained personnel and emergency therapies are available. Warning signs can include:

Trouble breathing, wheezing, or difficulty swallowing
Swelling of the face, lips, tongue, throat, or eyes
Hives, widespread itching, or rash
Chest discomfort, fainting, severe dizziness, or loss of consciousness
A rapid, weak pulse or cold, clammy skin

Patients should tell the prescribing professional about previous reactions to IV iron, allergies, pregnancy or plans for pregnancy, breastfeeding, high blood pressure, intestinal disorders, and all medicines and supplements they use. People with a known allergy to ferric carboxymaltose or Injectafer ingredients should not receive it.

When to Seek Care

Contact a primary care clinician if ongoing fatigue, weakness, paleness, headaches, rapid heartbeat, reduced exercise tolerance, or shortness of breath may indicate anemia. Depending on the suspected cause, evaluation may also involve a hematologist, gastroenterologist, gynecologist, kidney specialist, or cardiologist.

During or immediately after an infusion, report any new symptom to the medical staff. Seek emergency care for breathing difficulty, facial or throat swelling, fainting, chest pain, or other signs of a severe reaction. After treatment, promptly contact the prescribing clinician about persistent muscle weakness, worsening fatigue, bone or joint pain, or a possible fracture, as these symptoms may warrant a phosphate test and further evaluation.

The Bottom Line

Injectafer is the U.S. ferric carboxymaltose brand name. It can replenish iron when oral treatment is not tolerated, does not work adequately, or is unsuitable for certain patients. Because the treatment has meaningful risks—including allergic reactions, increased blood pressure, skin staining, and low phosphate—it should be administered and monitored by qualified healthcare professionals. The best results come from confirming iron deficiency, treating its underlying cause, and completing recommended follow-up testing.